System and sensor array
The present disclosure provides a system comprising a communication interface and computer for assigning a label to the biomolecule fingerprint, wherein the label corresponds to a biological state. The present disclosure also provides a sensor arrays for detecting biomolecules and methods of use. In some embodiments, the sensor arrays are capable of determining a disease state in a subject.
1. A kit comprising:
superparamagnetic particles comprising (i) iron oxide, (ii) silica and (iii) a negatively charged surface comprising carboxylate or carboxylic acid functional groups, and varying in sizes including from about 1000 nm to about 5000 nm in at least one direction, wherein the superparamagnetic particles are capable of binding a plurality of proteins in a biofluid to produce protein coronas;
a reducing agent configured to reduce proteins;
an alkylating agent configured to alkylate proteins;
an enzymatic agent configured to digest proteins;
a halting agent configured to halt the enzymatic agent; and
an adsorbent material configured for solid phase extraction of digested proteins obtained from the protein corona.
2. The kit of claim 1 , wherein the superparamagnetic particles are capable of producing protein coronas comprising (i) a first protein from the biofluid, and (ii) a second protein from the biofluid, wherein the second protein is present at a concentration greater than 6 magnitudes than the first protein in the biofluid.
3. The kit of claim 1 , wherein the superparamagnetic particles vary in sizes including from about 1000 nm to about 10000 nm in at least one direction.
4. The kit of claim 1 , wherein the superparamagnetic particles are capable of producing protein coronas from the biofluid comprising human plasma or serum.
5. The kit of claim 1 , wherein the enzymatic agent comprises trypsin.
6. The kit of claim 1 , further comprising a wash buffer configured to remove unbound and loosely attached proteins from the protein corona.
7. A kit comprising:
first superparamagnetic particles that are no more than about 3 μm in at least one direction and second superparamagnetic particles that are at least about 4 μm in at least one direction, wherein the first superparamagnetic particles and the second superparamagnetic particles comprise (i) iron oxide, (ii) silica and (iii) a negatively charge surface, and are capable of binding a plurality of proteins in a biofluid to produce protein coronas;
a reducing agent configured to reduce proteins;
an alkylating agent configured to alkylate proteins;
an enzymatic agent configured to digest proteins;
a halting agent configured to halt the enzymatic agent; and
an adsorbent material configured for solid phase extraction of digested proteins obtained from the protein corona.
8. The kit of claim 7 , wherein the first superparamagnetic particles and the second superparamagnetic particles are capable of producing protein coronas comprising (i) a first protein from the biofluid, and (ii) a second protein from the biofluid, wherein the second protein is present at a concentration greater than 6 magnitudes than the first protein in the biofluid.
9. The kit of claim 7 , wherein the first superparamagnetic particles and the second superparamagnetic particles are capable of producing protein coronas from the biofluid comprising human plasma or serum.
10. The kit of claim 9 , wherein the enzymatic agent comprises trypsin.
11. The kit of claim 7 , further comprising a wash buffer configured to remove unbound and loosely attached proteins from the protein corona.
12. The kit of claim 7 , further comprising third superparamagnetic particles comprising nanoparticles.
13. The kit of claim 12 , wherein the nanoparticles are no more than 100 nm in at least one direction.